AnalystsTony ButlerTony Butler's Stock Forecasts
AnalystsTony Butler
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4811 out of 4868 analysts
Average Return
-16.74%
Win Rate
32%38 out of 118
Risk vs Reward
Poor
Good
Tony Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +149.13% | $19.46 | $48.48 | 2023-03-01 - 2024-02-29 | Strong Buy |
Compugen LtdCGEN | +144.09% | $0.93 | $2.27 | 2023-05-24 - 2024-05-23 | Strong Buy |
Compugen LtdCGEN | +130.19% | $1.06 | $2.44 | 2023-05-26 - 2024-05-24 | Strong Buy |
Merus NvMRUS | +113.41% | $22.96 | $49.00 | 2023-08-08 - 2024-08-07 | Strong Buy |
Translate Bio IncTBIO1 | +113.12% | $17.76 | $37.85 | 2021-03-18 - 2021-08-04 | Strong Buy |
Tony Butler Analyst Color
Get additional color on Tony Butler's coverage of popular stocks
Tony Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atara Biotherapeutics IncATRA | 2 | Strong Buy | $25.00 | +212.89% | Initiates Coverage On | 4 months ago |
Tuhura Biosciences IncHURA | 1 | Strong Buy | $11.00 | +191.01% | Initiates Coverage On | 4 months ago |
Biomea Fusion IncBMEA | 4 | Strong Buy | $18.00 | +757.14% | Upgrades | 7 months ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $15.00 | +470.34% | Initiates Coverage On | 10 months ago |
Leap Therapeutics IncLPTX | 1 | Strong Buy | $8.00 | +1,813.88% | Initiates Coverage On | 10 months ago |
Century Therapeutics IncIPSC | 5 | Strong Buy | $16.00 | N/A | Reiterates | 2 years ago |
Adaptimmune Therapeutics PLCADAP | 8 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Fate Therapeutics IncFATE | 4 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Crispr Therapeutics AgCRSP | 7 | Strong Buy | $75.00 | N/A | Reiterates | 2 years ago |
Merus NvMRUS | 7 | Strong Buy | $35.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 5 | Hold | $60.00 | N/A | Reiterates | 2 years ago |
Compugen LtdCGEN | 6 | Strong Buy | $13.00 | N/A | Reiterates | 2 years ago |
Bicycle Therapeutics PLCBCYC | 5 | Strong Buy | $50.00 | N/A | Reiterates | 2 years ago |
Allogene Therapeutics IncALLO | 7 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
G1 Therapeutics IncGTHX | 4 | Strong Buy | $19.00 | N/A | Reiterates | 2 years ago |
Bioatla IncBCAB | 6 | Strong Buy | $25.00 | N/A | Reiterates | 2 years ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Viracta Therapeutics IncVIRX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Cel Sci CorpCVM | 3 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Calcimedica IncCALC | 2 | Strong Buy | $17.00 | N/A | Reiterates | 2 years ago |
Agenus IncAGEN | 4 | Strong Buy | $166.00 | N/A | Reiterates | 2 years ago |
Replimune Group IncREPL | 4 | Strong Buy | $60.00 | N/A | Reiterates | 2 years ago |
In8bio IncINAB | 4 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Aravive IncARAV | 5 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $6.00 | N/A | Assumes | 2 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $360.00 | N/A | Assumes | 2 years ago |
Rain Oncology IncRAIN2 | 6 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Apexigen IncAPGN | 4 | Hold | $0.64 | N/A | Reiterates | 2 years ago |
Ocean Biomedical IncOCEA | 1 | Strong Buy | $17.00 | N/A | Assumes | 2 years ago |
Atreca IncBCEL | 2 | Strong Buy | $10.00 | N/A | Reiterates | 2 years ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Ayala Pharmaceuticals IncAYLA | 2 | Strong Sell | $0.55 | N/A | Downgrades | 3 years ago |
Humanigen IncHGENQ | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Translate Bio IncTBIO1 | 4 | Hold | $684.00 | N/A | Maintains | 4 years ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $110.00 | N/A | Maintains | 4 years ago |
Panbela Therapeutics IncPBLA | 1 | Strong Buy | $240,000.00 | N/A | Initiates Coverage On | 4 years ago |
Nextcure IncNXTC | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 5 years ago |
Arqule IncARQL | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.